Oncorus Price To Book vs. Shares Outstanding

ONCRDelisted Stock  USD 0.04  0.01  14.71%   
Based on Oncorus' profitability indicators, Oncorus may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Oncorus' ability to earn profits and add value for shareholders.
For Oncorus profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Oncorus to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Oncorus utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Oncorus's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Oncorus over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Please note, there is a significant difference between Oncorus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncorus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncorus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Oncorus Shares Outstanding vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Oncorus's current stock value. Our valuation model uses many indicators to compare Oncorus value to that of its competitors to determine the firm's financial worth.
Oncorus is regarded second in price to book category among its peers. It is considered to be number one stock in shares outstanding category among its peers creating about  206,120,063  of Shares Outstanding per Price To Book. Comparative valuation analysis is a catch-all technique that is used if you cannot value Oncorus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Oncorus Shares Outstanding vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Oncorus

P/B

 = 

MV Per Share

BV Per Share

 = 
0.13 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Oncorus

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
26.09 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Oncorus Shares Outstanding Comparison

Oncorus is currently under evaluation in shares outstanding category among its peers.

Oncorus Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Oncorus, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Oncorus will eventually generate negative long term returns. The profitability progress is the general direction of Oncorus' change in net profit over the period of time. It can combine multiple indicators of Oncorus, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Oncorus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.

Oncorus Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Oncorus. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Oncorus position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Oncorus' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Oncorus without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Use Investing Themes to Complement your Oncorus position

In addition to having Oncorus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Growth Thematic Idea Now

Tech Growth
Tech Growth Theme
Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. The Tech Growth theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Growth Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Oncorus Stock

If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Managers
Screen money managers from public funds and ETFs managed around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency